VTRS

Viatris Inc Ord Shs

9.86

0.12+1.23%

After Hours: 9.82 -0.04 -0.41%19:35 10/13 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE9.78/9.74

TODAY RANGE9.74-9.97

VOL7.62M

MARKET CAP11.50B

52 WEEK RANGE6.68-13.04

AVG VOL (3M)9.44M

% TURNOVER0.65%

TURNOVER--

P/E (TTM)-3.3896

% RANGE2.31%

EPS(TTM)-2.9089

P/E(FORWARD)-3.9342

P/B0.7382

BVPS13.36

DIVIDEND0.4800

P/S0.7985

BETA--

DIV YIELD4.87%

FREE FLOAT MKT CAP11.46B

SHARES OUTSTANDING1.17B

NEXT EARNINGS11/05-11/10

FREE FLOAT1.16B

LOT SIZE1

EX-DATE08/22/2025

News

Press Releases

Financial Reports

Profile

Reuters·19h ago
Viatris Inc. to Participate in UBS and Jefferies Global Healthcare Conferences
PR Newswire·19h ago
Viatris to Participate in Upcoming Investor Conferences
Seeking Alpha·1d ago
Buy Any Of 14 IDEAL 'Safer' S&P 500 October Dividend Dogs
Seeking Alpha·4d ago
Biogen's Comeback: Why The Bulls Are Finally Winning Again
PR Newswire·5d ago
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row
Seeking Alpha·10/06 20:01
Viatris shares break six-session winning streak
Seeking Alpha·10/06 17:29
My Top 5 Biotech Stocks Big Pharma Could Buy Next
Seeking Alpha·10/03 19:05
FDA introduces program to expedite review of domestic generic drugs
PR Newswire·10/01 13:00
Viatris to Report Third Quarter 2025 Financial Results on November 6, 2025
NASDAQ·09/29 10:42
Look Under The Hood: QVML Has 11% Upside
Seeking Alpha·09/25 17:16
Viatris: Indore Plant Could Boost 2026 Numbers
Seeking Alpha·09/25 15:42
Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors
Reuters·09/24 11:00
Indian drugmakers Dr Reddy's, Hetero to sell generic HIV prevention drug for $40 a year
Seeking Alpha·09/23 01:09
Tracking David Einhorn's Greenlight Capital Portfolio - Q2 2025 Update
NASDAQ·09/18 19:24
Viatris (VTRS) Shares Cross 5% Yield Mark

Same Industry

Name/Symbol

Change%

Price

Viatris Inc Ord Shs

VTRS

+1.23%

9.86

McKesson

MCK

+0.78%

769.49

Biogen Inc

BIIB

-1.28%

144.69

Amgen Inc

AMGN

+0.78%

292.41

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-10.06%

0.0313

Lilly Eli & Co

LLY

-1.69%

819.40

Celgene

CELG

108.24

Therapeuticsmd Inc

TXMD

+0.93%

1.05

Johnson & Johnson

JNJ

+0.09%

190.90

Abbvie Inc

ABBV

-0.09%

230.30

Zoetis Inc

ZTS

+0.82%

142.26

Gilead Sciences Inc

GILD

+0.88%

118.21

Novo-Nordisk A/S

NVO

+1.00%

57.50

Bristol-Myers Squibb Co

BMY

-0.96%

43.54

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-0.20%

24.73

Sanofi FR

SNY

+1.48%

48.80

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.70%

129.12

Dr Reddys Labs

RDY

+0.14%

14.36

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.